Medical Subject Headings

Last uploaded: January 31, 2024
Preferred Name

Biomarkers, Tumor

Synonyms

Metabolite Markers, Tumor

Neoplasm Metabolite Markers

Definitions

Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.

ID

http://purl.bioontology.org/ontology/MESH/D014408

altLabel

Metabolite Markers, Tumor

Tumor Biomarkers

Marker, Biochemical Tumor

Tumor Metabolite Markers

Markers, Carcinogen

Marker, Tumor

Tumor Markers, Biologic

Biomarkers, Cancer

Cancer Biomarkers

Biochemical Tumor Markers

Neoplasm Metabolite Marker

Markers, Tumor Metabolite

Marker, Biological Tumor

Markers, Biochemical Tumor

Biological Tumor Marker

Biologic Tumor Markers

Metabolite Marker, Tumor

Tumor Biomarker

Markers, Biologic Tumor

Marker, Neoplasm Metabolite

Biologic Tumor Marker

Markers, Biological Tumor

Metabolite Markers, Neoplasm

Cancer Biomarker

Tumor Marker, Biochemical

Tumor Marker, Biologic

Marker, Tumor Metabolite

Biological Tumor Markers

Tumor Markers, Biological

Biomarker, Cancer

Metabolite Marker, Neoplasm

Markers, Tumor

Tumor Markers, Biochemical

Tumor Markers

Biomarker, Tumor

Tumor Metabolite Marker

Tumor Marker, Biological

Tumor Marker

Carcinogen Markers

Marker, Biologic Tumor

Biochemical Tumor Marker

Markers, Neoplasm Metabolite

Neoplasm Metabolite Markers

AQL

AD AE AG AI AN BI BL CF CH CL CS DF EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR

cui

C0041365

C0041366

DC

1

definition

Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.

DX

19880101

HN

2016(1988)

Inverse of AQ

http://purl.bioontology.org/ontology/MESH/Q000097

http://purl.bioontology.org/ontology/MESH/Q000096

http://purl.bioontology.org/ontology/MESH/Q000172

http://purl.bioontology.org/ontology/MESH/Q000627

http://purl.bioontology.org/ontology/MESH/Q000493

http://purl.bioontology.org/ontology/MESH/Q000494

http://purl.bioontology.org/ontology/MESH/Q000276

http://purl.bioontology.org/ontology/MESH/Q000138

http://purl.bioontology.org/ontology/MESH/Q000134

http://purl.bioontology.org/ontology/MESH/Q000266

http://purl.bioontology.org/ontology/MESH/Q000378

http://purl.bioontology.org/ontology/MESH/Q000008

http://purl.bioontology.org/ontology/MESH/Q000009

http://purl.bioontology.org/ontology/MESH/Q000032

http://purl.bioontology.org/ontology/MESH/Q000037

http://purl.bioontology.org/ontology/MESH/Q000191

http://purl.bioontology.org/ontology/MESH/Q000302

http://purl.bioontology.org/ontology/MESH/Q000145

http://purl.bioontology.org/ontology/MESH/Q000592

http://purl.bioontology.org/ontology/MESH/Q000737

http://purl.bioontology.org/ontology/MESH/Q000819

http://purl.bioontology.org/ontology/MESH/Q000502

http://purl.bioontology.org/ontology/MESH/Q000506

http://purl.bioontology.org/ontology/MESH/Q000235

http://purl.bioontology.org/ontology/MESH/Q000633

http://purl.bioontology.org/ontology/MESH/Q000600

http://purl.bioontology.org/ontology/MESH/Q000652

http://purl.bioontology.org/ontology/MESH/Q000528

Inverse of RB

0

Inverse of RO

http://purl.bioontology.org/ontology/MESH/D009363

Machine permutation

2016; See TUMOR MARKERS, BIOLOGICAL 1988-2015

Mapped from

http://purl.bioontology.org/ontology/MESH/C081856

http://purl.bioontology.org/ontology/MESH/C516879

http://purl.bioontology.org/ontology/MESH/C516108

http://purl.bioontology.org/ontology/MESH/C116891

http://purl.bioontology.org/ontology/MESH/C432845

http://purl.bioontology.org/ontology/MESH/C496188

http://purl.bioontology.org/ontology/MESH/C115012

http://purl.bioontology.org/ontology/MESH/C000717670

http://purl.bioontology.org/ontology/MESH/C044672

http://purl.bioontology.org/ontology/MESH/C413062

http://purl.bioontology.org/ontology/MESH/C512821

http://purl.bioontology.org/ontology/MESH/C081121

http://purl.bioontology.org/ontology/MESH/C425469

http://purl.bioontology.org/ontology/MESH/C425183

http://purl.bioontology.org/ontology/MESH/C516892

http://purl.bioontology.org/ontology/MESH/C068379

http://purl.bioontology.org/ontology/MESH/C112999

http://purl.bioontology.org/ontology/MESH/C480232

http://purl.bioontology.org/ontology/MESH/C095157

MDA

19870327

MMR

20200527

MN

D23.101.140

notation

D014408

prefLabel

Biomarkers, Tumor

TERMUI

T042138

T042130

T000996599

T000866999

T042141

T042143

T042136

T042132

T042137

T042129

T042149

T042135

T042147

T042145

T042142

T042133

T042148

T042131

T042146

T042139

T042140

T042134

T042144

T000999615

T000996598

T000999616

T000882145

TH

NLM (2016)

NLM (1990)

NLM (1994)

UNK (19XX)

NLM (2021)

NLM (1988)

tui

T123

subClassOf

http://purl.bioontology.org/ontology/MESH/D015415

Delete Subject Author Type Created
No notes to display